# Clinical Trial in Males With BPH (Enlarged Prostate)

> **NCT00029822** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 1522 (actual)

## Conditions studied

- Urinary Retention
- Prostatic Hyperplasia
- Benign Prostatic Hypertrophy

## Interventions

- **DRUG:** Alfuzosin (SL770499)

## Key facts

- **NCT ID:** NCT00029822
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 1522 (ACTUAL)
- **Last updated:** 2008-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029822, "Clinical Trial in Males With BPH (Enlarged Prostate)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00029822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*